GlassScriptPhysician profile
Surjit K Mahal
NPI 1609920156
$1,284.08
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $481 · 2020: $134 · 2021: $433 · 2022: $216 · 2023: $19.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $235.87 | 2019-2022 | |
| Abbvie INC. | $183.25 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $139.08 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $137.11 | 2019-2021 | |
| Lilly USA, LLC | $79.94 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $71.45 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $55.99 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $52.06 | 2019-2020 | |
| Pfizer INC. | $38.30 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.72 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $37.23 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.77 | 2022 | |
| Glaxosmithkline, LLC. | $27.78 | 2022 | |
| Hologic Sales and Service, LLC | $25.00 | 2019 | |
| Gilead Sciences, INC. | $22.28 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $22.12 | 2020 | |
| Allergan, INC. | $21.55 | 2020 | |
| Eisai INC. | $19.42 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.71 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.11 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Surjit Mahal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.